These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 5055042)

  • 21. Penicillamine hypersensitivity: successful desensitization of a patient with severe hepatic Wilson's disease.
    Chan CY; Baker AL
    Am J Gastroenterol; 1994 Mar; 89(3):442-3. PubMed ID: 8122662
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Cholestatic jaundice induced by D-penicillamine and oral steroid contraceptive in progressive systemic sclerosis (author's transl)].
    Wozel G; Julius U
    Dtsch Z Verdau Stoffwechselkr; 1982; 42(2-3):85-93. PubMed ID: 6179735
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of systemic sclerosis with D-penicillamine. A new method of observing the effects of treatment.
    Bluestone R; Grahame R; Holloway V; Holt PJ
    Ann Rheum Dis; 1970 Mar; 29(2):153-8. PubMed ID: 5427411
    [No Abstract]   [Full Text] [Related]  

  • 24. Penicillamine for systemic sclerosis?
    Drug Ther Bull; 1974 Sep; 12(19):75-6. PubMed ID: 4469492
    [No Abstract]   [Full Text] [Related]  

  • 25. [D-penicillamine therapy of chronic polyarthritis].
    Günther R; Gabl F; Knapp E
    Z Rheumaforsch; 1973; 32(7):313-25. PubMed ID: 4741805
    [No Abstract]   [Full Text] [Related]  

  • 26. Asymptomatic annular plaques on the neck.
    Chabra IS; Grandinetti LM
    Cutis; 2014 Oct; 94(4):E1-3. PubMed ID: 25372260
    [No Abstract]   [Full Text] [Related]  

  • 27. [Morphology and pathogenesis of penicillamine-induced nephropathy].
    Henzgen S; Waldmann G
    Zentralbl Allg Pathol; 1983; 128(1-2):53-61. PubMed ID: 6637187
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Granulomatous hepatitis and parotiditis induced by d-penicillamine in a case of rheumatoid arthritis].
    Crickx L; Leger JM; Auquier L
    Nouv Presse Med; 1979 Jan; 8(3):212. PubMed ID: 554085
    [No Abstract]   [Full Text] [Related]  

  • 29. [Nephropathy in a patient with systemic scleroderma treated with D-penicillamine].
    Balabanova RM; Ivanova MM; Oskilko TG
    Ter Arkh; 1980; 52(4):119-21. PubMed ID: 7404326
    [No Abstract]   [Full Text] [Related]  

  • 30. [Minimal changes nephrotic syndrome associated to penicillamine treatment].
    Basterrechea MA; de Arriba G; García-Martín F; Sánchez-Heras M; Giménez-Vega E; Sánchez J
    Nefrologia; 2004; 24(2):183-7. PubMed ID: 15219094
    [TBL] [Abstract][Full Text] [Related]  

  • 31. D-penicillamine-induced crescentic glomerulonephritis in a patient with scleroderma.
    García-Porrúa C; González-Gay MA; Bouza P
    Nephron; 2000 Jan; 84(1):101-2. PubMed ID: 10644924
    [No Abstract]   [Full Text] [Related]  

  • 32. 65Zinc absorption in untreated and D-penicillamine-treated patients with generalized scleroderma: determination by whole-body counting technique.
    Høyer H; Hvid-Jacobsen K; Weismann K
    Acta Derm Venereol; 1982; 62(5):438-40. PubMed ID: 6183898
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [D-penicillamine-induced pemphigus: changes in anti-32-2B immunostaining patterns].
    Khashoggi M; Machet L; Perrinaud A; Brive D; Machet MC; Maruani A; Vaillant L
    Ann Dermatol Venereol; 2013; 140(8-9):531-4. PubMed ID: 24034638
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical and prognostic significance of antinuclear factors during D-penicillamine treatment (author's transl)].
    Helmke K; Velcovsky HG; Federlin K
    Dtsch Med Wochenschr; 1975 Oct; 100(43):2198-203. PubMed ID: 1080704
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Long-term use of D-penicillamine in systemic scleroderma and rheumatoid arthritis].
    Guseva NG; Trofimova TM; Oskilko TG; Panasiuk AF; Tarasenkova TA
    Klin Med (Mosk); 1986 Jun; 64(6):44-50. PubMed ID: 3747436
    [No Abstract]   [Full Text] [Related]  

  • 36. [Treatment of generalized scleroderma with connective tissue inhibitors].
    Asboe-Hansen G
    Ugeskr Laeger; 1976 May; 138(22):1325-9. PubMed ID: 1273949
    [No Abstract]   [Full Text] [Related]  

  • 37. In vitro inhibition of hematopoiesis in a patient with systemic sclerosis treated with D-penicillamine.
    Katayama Y; Kohriyama K; Matsui T
    J Rheumatol; 1999 Nov; 26(11):2493-5. PubMed ID: 10555917
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pemphigus vulgaris induced by D-penicillamine therapy in a patient with systemic sclerosis.
    Shapiro M; Jimenez S; Werth VP
    J Am Acad Dermatol; 2000 Feb; 42(2 Pt 1):297-9. PubMed ID: 10642693
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vesicular lesions in a woman with progressive systemic sclerosis. Penicillamine-induced intradermal vesicles: an example of human lathyrism.
    Godar JM; Norins AL
    Arch Dermatol; 1992 Jul; 128(7):977-8, 980-1. PubMed ID: 1626968
    [No Abstract]   [Full Text] [Related]  

  • 40. [Therapeutic use of d-penicillamine].
    Bogdanikowa B
    Pol Tyg Lek; 1972 Oct; 27(41):1612-3. PubMed ID: 4581541
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.